Codiagnostics, Inc. (CODX) SEC Filing 8-K Material Event for the period ending Thursday, June 20, 2019

Codiagnostics, Inc.

CIK: 1692415 Ticker: CODX

View differences made from one to another to evaluate Codiagnostics, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Codiagnostics, Inc..


Assess how Codiagnostics, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Codiagnostics, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Codiagnostics, Inc. provided additional information to their SEC Filing as exhibits

Ticker: CODX
CIK: 1692415
Form Type: 8-K Corporate News
Accession Number: 0001493152-19-009755
Submitted to the SEC: Wed Jun 26 2019 5:29:48 PM EST
Accepted by the SEC: Wed Jun 26 2019
Period: Thursday, June 20, 2019
Industry: Surgical And Medical Instruments And Apparatus
  1. Event for Officers
  2. Financial Exhibit

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: